-- Preview Email Newsletter
| Journals Medical Newsletter for 2026-11-10 ( 19 items ) |
|
ACP and OpenEvidence collaborate to enhance physician access to trusted clinical guidance (10)
PHILADELPHIA, Pennsylvania, Nov. 9 [Category: Medical] -- The American College of Physicians posted the following news release:
* * *
ACP and OpenEvidence collaborate to enhance physician access to trusted clinical guidance
*
Licensing agreement will integrate ACP content into OpenEvidence's clinical decision support platform
MIAMI, FL and PHILADELPHIA, PA, November 5, 2026 -- The American College of Physicians (ACP), the largest medical specialty organization in the US, and OpenEvidence, the most popular AI for doctors in the United State more PR
ACS and SIR Call for Team-Based Bleeding Control in Trauma Care (10)
CHICAGO, Illinois, Nov. 9 [Category: Medical] -- The American College of Surgeons issued the following news release:
* * *
ACS and SIR Call for Team-Based Bleeding Control in Trauma Care
*
FAIRFAX, Va. -- The American College of Surgeons (ACS) Committee on Trauma and the Society of Interventional Radiology (SIR) have issued a joint position statement reaffirming the role of interventional radiologists on multidisciplinary trauma teams and the importance of establishing reliable systems for rapid endovascular hemorrhage control in trauma sit more PR
AI-analysis of ECG data measured by smartwatch may help detect reduced heart pumping function (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
AI-analysis of ECG data measured by smartwatch may help detect reduced heart pumping function
*
Research Highlights:
* An artificial intelligence (AI) model analyzed ECG recordings from two different brands of smartwatches for more than 2,200 adults in South Korea. The study found that the AI model was able to identify people with and without reduced heart pumping function, or left ventricular systolic dysfunction (LVSD) more PR
AI-interpreted echocardiograms comparable to human reports, cardiologists' time cut by about 50% (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
AI-interpreted echocardiograms comparable to human reports, cardiologists' time cut by about 50%
*
Research Highlights:
* In a study to test an artificial intelligence (AI) model for evaluating heart ultrasound exams (echocardiograms), the AI-assisted interpretations were comparable in accuracy to preliminary interpretations prepared by sonographers and cardiologists.
* Having AI-generated preliminary interpretations re more PR
Bayer's asundexian first FXIa inhibitor approved by U.S. Food and Drug Administration for secondary stroke risk reduction (10)
LEVERKUSEN, Germany, Nov. 10 [Category: BizPharmaceuticals] -- Bayer Group, a pharmaceutical and life sciences company, posted the following news release:
* * *
Bayer's asundexian first FXIa inhibitor approved by U.S. Food and Drug Administration for secondary stroke risk reduction
*
Berlin, November 10, 2026 - Bayer announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for asundexian, 50 mg tablets, under the brand name Sunharbo(r). The product is indicated in combination with antiplatelet the more PR
Bayer's SUNHARBO(r) (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S. FDA to Reduce the Risk of Stroke in Adults With Recent Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, in Combination (10)
WHIPPANY, New Jersey, Nov. 9 [Category: BizPharmaceuticals] -- Bayer USA, an enterprise with core competencies in the life science fields of health care and nutrition, posted the following news:
* * *
Bayer's SUNHARBO(r) (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S. FDA to Reduce the Risk of Stroke in Adults With Recent Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, in Combination With Antiplatelet Therapy
*
* The full indication for SUNHARBO(r) (asundexian) is to reduc more PR
Boehringer Ingelheim: CVMP Adopts a Positive Opinion for SCOVELLA, First Therapy for Hyperinsulinaemia in Horses With Equine Metabolic Syndrome (10)
INGELHEIM AM RHEIN, Germany, Nov. 10 (TNSrep)-- Boehringer Ingelheim, a pharmaceutical company, issued the following news release:
* * *
CVMP adopts a positive opinion for SCOVELLA(R), the first therapy for hyperinsulinaemia in horses with Equine Metabolic Syndrome
Ingelheim, Germany 10/11/2026
* SCOVELLA(R) was developed to reduce hyperinsulinaemia in insulin-dysregulated horses, a key underlying driver of laminitis - a common, painful inflammatory condition in horses' hooves and significant unmet need in equine health.
Laminitis is one more PR
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight (10)
DALLAS, Texas, Nov. 9 [Category: Health Care] -- The American Heart Association posted the following news release:
* * *
Daily, oral GLP-1 medication reduced episodes of sleep apnea in adults with excess weight
*
Research Highlights:
* In two, separate, year-long clinical trials, adults with moderate-to-severe sleep apnea and excess weight (BMI >=27 kg/m2) who took the oral GLP-1 medication orforglipron, had about 18 fewer breathing interruptions per hour of sleep after 52 weeks, compared with about 5 fewer breathing interruptions per hour more PR
HKU Engineering Researchers Develop the World's 1st Megawatt Ultra-wide Bandgap Semiconductor Module for Next-generation High-power Electronics (10)
HONG KONG, Nov. 9 -- The University of Hong Kong issued the following news release:
* * *
HKU Engineering Researchers Develop the World's 1st Megawatt Ultra-wide Bandgap Semiconductor Module for Next-generation High-power Electronics
8 Nov 2026
Researchers from the Department of Electrical and Computer Engineering under the Faculty of Engineering at the University of Hong Kong (HKU) and the Centre for Advanced Semiconductors and Integrated Circuits (CASIC) have achieved a major breakthrough in next-generation power electronics. The team has more PR
Iowa Cancer Rates Continue to Rise, Largely Driven by Prostate and Breast Cancer Diagnoses (10)
ATLANTA, Georgia, Nov. 9 [Category: Medical] -- The American Cancer Society posted the following news release:
* * *
Iowa Cancer Rates Continue to Rise, Largely Driven by Prostate and Breast Cancer Diagnoses
*
Key Takeaways:
* Iowa's overall cancer rate increased among men and women while remaining stable in surrounding states.
* Rise in cancer incidence driven largely by early-stage prostate and breast cancers.
* Increased detection, clinical evaluation, or imaging or tests done for other reasons linked to a higher number of cancer diag more PR
Joseph Hill, M.D., Ph.D., receives two American Heart Association awards (10)
DALLAS, Texas, Nov. 9 -- The University of Texas Southwestern Medical Center posted the following news release:
* * *
Joseph Hill, M.D., Ph.D., receives two American Heart Association awards
*
Distinguished Scientist and Council on Basic Cardiovascular Sciences Distinguished Achievement honors reflect UTSW cardiologist's numerous impactful discoveries
DALLAS - Nov. 09, 2026 - Joseph Hill, M.D., Ph.D., Professor of Internal Medicine in the Division of Cardiology and Professor of Molecular Biology at UT Southwestern Medical Center, has recei more PR
New treatment may cure common hormonal cause of high blood pressure (10)
LONDON, England, Nov. 9 -- Queen Mary University of London issued the following news:
* * *
New treatment may cure common hormonal cause of high blood pressure
*
A study led by Queen Mary University of London has found that a new treatment could offer a lasting cure for some people with a common hormonal cause of high blood pressure, even after they stop taking medication.
The treatment, known as extended aldosterone synthase inhibition (EASI), involves taking a new class of drugs for 6-12 months to target excess production of the hormone more PR
Q&A: How can organizations improve fairness in automated AI systems? (10)
UNIVERSITY PARK, Pennsylvania, Nov. 9 -- Pennsylvania State University posted the following news:
* * *
Q&A: How can organizations improve fairness in automated AI systems?
*
UNIVERSITY PARK, Pa. -- Critical decisions are increasingly being made by artificial intelligence (AI) systems in high-stakes industries like healthcare, criminal justice and finance, ushering in a wave of ethical and legal concerns over how these systems can be implemented fairly. Now, a new study by a Penn State researcher and collaborators proposes a holistic theory more PR
Research snapshot: Discover how Spears Business is impacting the world (10)
STILLWATER, Oklahoma, Nov. 9 -- Oklahoma State University issued the following news:
* * *
Research snapshot: Discover how Spears Business is impacting the world
*
Media Contact: Hallie Hart | Communications Coordinator | 405-744-1050 | hallie.hart@okstate.edu
Key Facts
* Dr. Aman Kabra's recent publication introduces a three-dimensional framework for evaluating experts in a group.
* Dr. Harounan Kazianga's recent publication examines the lasting educational, economic and agricultural effects of a public health initiative in Burkina Faso more PR
UCLA Health Jonsson Comprehensive Cancer Center: Drug Combination Improves Survival in Patients With Muscle-invasive Bladder Cancer (10)
LOS ANGELES, California, Nov. 10 (TNSjou) -- The UCLA Health Jonsson Comprehensive Cancer Center issued the following news release:
* * *
New drug combination improves survival in patients with muscle-invasive bladder cancer
Study finds that combining immunotherapy with a targeted cancer drug before surgery, followed by immunotherapy, reduces the risk of death by 42% in patients unable to receive standard chemotherapy
November 9, 2026
A new treatment approach could help people with an aggressive form of bladder cancer live longer and reduc more PR
UConn's Professor Sir Cato T. Laurencin Receives Leadership and Advocacy Award from InterCommunity Health Care (10)
STORRS, Connecticut, Nov. 9 -- The University of Connecticut posted the following news:
* * *
UConn's Professor Sir Cato T. Laurencin Receives Leadership and Advocacy Award from InterCommunity Health Care
*
Professor Sir Cato T. Laurencin, MD, PhD, KCSL, received InterCommunity Health Care's Leadership and Advocacy Award during the Hartford County-based nonprofit's annual gala, hosted at the Hartford Marriott Downtown in October. Laurencin was honored with the distinction for the advancements he's made in science, medicine, and engineering, more PR
UM Team Overcomes Robotic Grasping Challenges to Boost Universal Intelligent Manipulation (10)
MACAU, China, Nov. 9 -- The University of Macau posted the following news:
* * *
UM Team Overcomes Robotic Grasping Challenges to Boost Universal Intelligent Manipulation
*
A research team led by Professor Xu Qingsong in the Faculty of Engineering at the University of Macau (UM), has achieved a breakthrough in the field of universal robotic manipulation. The team has developed a comprehensive framework for universal robotic grasping that can be adapted to complex scenarios, enabling the rapid deployment of customised and commercial robotic more PR
UMSL Alumni Featured Among St. Louis Business Journal's Newest 40 Under 40 Class (10)
ST. LOUIS, Missouri, Nov. 9 -- The University of Missouri St. Louis campus posted the following news:
* * *
UMSL alumni featured among St. Louis Business Journal's newest 40 Under 40 class
By Steve Walentik | Nov 9, 2026
Charli Cooksey, Kevin Cox and Cyril Loum were highlighted for the early career impact they're making across the St. Louis region.
The University of Missouri-St. Louis continues to be a proud sponsor of the St. Louis Business Journal's annual 40 Under 40 Awards, which celebrate the best and brightest young professionals in more PR
Wrist-worn device launched by Imperial startup aims to cut IV complications in hospitals (10)
LONDON, England, Nov. 9 -- Imperial College-London issued the following news:
* * *
Wrist-worn device launched by Imperial startup aims to cut IV complications in hospitals
*
A UK startup linked to Imperial College London has launched a wrist-worn device for securely attaching intravenous drip lines to patients, designed to reduce treatment interruptions and help the NHS bring down the substantial costs of replacing failed lines.
Javelo was founded Dr Ashton Barnett-Vanes, a medical doctor with a PhD from Imperial, after he saw first-hand more PR
|
